USES OF NOSCAPINE AND DERIVATIVES IN SUBJECTS DIAGNOSED WITH FAP
摘要
<p>This disclosure relates to methods of treating or preventing cancer comprising administering a pharmaceutical composition comprising noscapine or noscapine derivatives to a subject diagnosed with a mutated adenomatous polyposis coli (APC) gene.</p>
